✦ LIBER ✦

Combination chemotherapy with cis-platin (CDDP), epirubicin (EPI), and docetaxel (DOC) in transitional cell urothelial cancer (TCC). A phase II study

✍ Scribed by Pectasides, D.; Visvikis, A.; Aspropotamitis, A.; Halikia, A.; Kalantaridou, A.; Batzios, S.; Karvounis, N.; Athanassiou, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy with cisplatin, epirubicin

✍ D Pectasides; A Visvikis; A Aspropotamitis; A Halikia; N Karvounis; M Dimitriadi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Combination chemotherapy with carboplati

✍ Pectasides, D.; Aspropotamitis, A.; Halikia, A.; Visvikis, A.; Antoniou, F.; Kal 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A phase II study of docetaxel and vinore

✍ J Bennouna; A Monnier; A Rivière; B Milleron; E Lemarie; V Trillet-Lenoir; K Sou 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 97 KB

A phase II study of chronomodulated (CHR

✍ Bertuccelli, M.; Falcone, A.; Brunetti, I.; Pfanner, E.; Allegrini, G.; Panduri, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Phase II study on sequential chemotherap

✍ Casadio, M.; Martoni, A.; Melotti, B.; Pajetta, V.; Busutti, L.; Pannuti, F. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Weekly regimen of epirubicin and paclita

✍ Antonio Rozzi; Margherita Salerno; Francesca Bordin; Ferdinando De Marco; Stefan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 316 KB